1,058 resources
Start Prev Rows 600 - 800 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Source(s) |
---|---|---|---|---|---|---|---|---|---|
smart.who.int.anc | R4 | anc-b9-de66-choices-grouper | Hepatitis B test result Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b9-de92-choices-grouper | Hepatitis C diagnosis Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b9-de89-choices-grouper | Hepatitis C test result Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b7-de1-choices-grouper | Medication follow-up Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b9-de129-choices-grouper | Midstream urine Gram-staining Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b9-de124-choices-grouper | Midstream urine culture (recommended) Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b6-de7-choices-grouper | Occupation Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b9-de55-choices-grouper | Partner HIV status (confirmed) Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b6-de156-choices-grouper | Partner HIV status (reported) Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b9-de48-choices-grouper | Partner HIV test result Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b6-de34-choices-grouper | Past pregnancy complications Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b8-de79-choices-grouper | Pelvic exam result (visual) Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b7-ded9-choices-grouper | Persistent behaviours Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b7-de18-choices-grouper | Persistent physiological symptoms Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b10-de137-choices-grouper | Planned birth place Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b7-de71-choices-grouper | Presenting signs and symptoms that trigger suspicion of IPV and clinical inquiry Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b5-de1-choices-grouper | Reason for coming to facility Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b8-de39-choices-grouper | Respiratory exam result Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b9-de29-choices-grouper | Rh factor Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b8-de27-choices-grouper | Symptoms of severe pre-eclampsia Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b9-de110-choices-grouper | Syphilis diagnosis Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b9-de107-choices-grouper | Syphilis test result Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b9-de98-choices-grouper | Syphilis test type Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b9-de206-choices-grouper | TB screening result Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b6-de100-choices-grouper | Tetanus toxoid-containing vaccine (TTCV) immunization history Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b9-de150-choices-grouper | Urine dipstick result - glucose Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b9-de138-choices-grouper | Urine dipstick result - leukocytes Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b9-de132-choices-grouper | Urine dipstick result - nitrites Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b9-de144-choices-grouper | Urine dipstick result - protein Choices Grouper | draft | 2021-09 | uv | internal | ||
smart.who.int.anc | R4 | anc-b8-de5-choices-grouper | Weight category Choices Grouper | draft | 2021-09 | uv | internal | ||
who.ddcc | R4 | ICAOV1ValueSet | DDCC Codes for ICAO Vaccines | draft | 2025-06 | uv | internal | ||
smart.who.int.anc | R4 | iron-supplement | Iron Supplement | draft | 2025-06 | uv | internal | ||
smart.who.int.ips-pilgrimage | R4 | Language | Language | draft | 2025-05 | internal | |||
smart.who.int.ips-pilgrimage | R4 | LicensingModel | Licensing Model | draft | 2025-05 | internal | |||
smart.who.int.ips-pilgrimage | R4 | OperatingSystem | Operating System | draft | 2025-05 | internal | |||
smart.who.int.anc | R4 | pregnancy-condition | Pregnancy condition | draft | 2025-06 | uv | internal | ||
smart.who.int.pcmt | R4 | NameType | Name Type for a Product | draft | 2025-07 | fhir | |||
smart.who.int.pcmt | R4 | ProductRelationship | Product Relationships | draft | 2025-07 | internal | |||
smart.who.int.pcmt | R4 | AttributeType | AttributeType for a Product | draft | 2025-07 | internal | |||
smart.who.int.pcmt | R4 | Status | Status for a Product | draft | 2025-07 | internal | |||
who.ddcc | R4 | DDCCDevicePropertyValueSet | DDCC Device Property Codes | draft | 2025-06 | uv | internal | ||
smart.who.int.pcmt | R4 | RegulationType | Regulation Type for a Regulated Product | draft | 2025-07 | internal | |||
smart.who.int.trust-phw | R4 | DVCRelationshipStatus | Relationship Status for Contact in Patient | draft | 2025-07 | uv | |||
who.ddcc | R4 | VaccineCovid19CvxValueSet | Vaccine - COVID-19 - CVX | draft | 2025-06 | uv | cvx | ||
who.ddcc | R4 | VaccineCovid19SnomedValueSet | Vaccine - COVID-19 - SNOMED CT | draft | 2025-06 | uv | sct | ||
who.ddcc | R4 | LabTestTypeCovid19LoincValueSet | Lab Test - Type - COVID-19 - LOINC | draft | 2025-06 | uv | loinc | ||
who.ddcc | R4 | LabTestTypeLoincValueSet | Lab Test - Type - Generic - LOINC | draft | 2025-06 | uv | loinc | ||
who.ddcc | R4 | LabTestQualitativeResultSnomedValueSet | Lab Test - Qualitative Result - SNOMED CT | draft | 2025-06 | uv | sct | ||
who.ddcc | R4 | LabTestResultIcaoValueSet | Lab Test - Qualitative Result - ICAO | draft | 2025-06 | uv | internal | ||
who.ddcc | R4 | LabTestQualitativeResultDivocValueSet | Lab Test - Qualitative Result - DIVOC | draft | 2025-06 | uv | internal | ||
who.ddcc | R4 | lab-test-sample-origin-icao | Lab Test - Sample Origin - ICAO | draft | 2025-06 | uv | internal | ||
who.ddcc | R4 | lab-test-sample-origin-divoc | Lab Test - Sample Origin - DIVOC | draft | 2025-06 | uv | internal | ||
who.ddcc | R4 | LabTestTypeIcaoValueSet | Lab Test - Type - ICAO | draft | 2025-06 | uv | internal | ||
who.ddcc | R4 | LabTestTypeDivocValueSet | Lab Test - Type - DIVOC | draft | 2025-06 | uv | internal | ||
who.ddcc | R4 | LabTestPathogenCovid19SnomedValueSet | Lab Test - Pathogen - COVID-19 - SNOMED CT | draft | 2025-06 | uv | sct | ||
who.ddcc | R4 | LabTestPathogenDivocValueSet | Lab Test - Pathogen - DIVOC | draft | 2025-06 | uv | internal | ||
smart.who.int.trust-phw | R4 | DVCVaccines | DVC - Vaccines | draft | 2025-07 | uv | |||
smart.who.int.icvp | R4 | ICVPVaccineCodes | ICVP - Vaccine Codes | draft | 2025-07 | ||||
who.ddcc | R4 | DDCCQRTypeValueSet | DDCC QR Type Codes | draft | 2025-06 | uv | internal | ||
who.ddcc | R4 | VaccineCovid19EUUnionRegisterValueSet | Vaccine - COVID-19 - EU Union Register of Medicinial Products | draft | 2025-06 | uv | |||
smart.who.int.icvp | R4 | VaccineManufacturer | VaccineManufacturer | draft | 2025-07 | internal | |||
smart.who.int.base | R4 | CDHIv1 | Classification of Digital Health Interventions v1 | active | 2025-07 | internal | |||
smart.who.int.base | R4 | CDSCv1 | Classification of Digital Health System Categories v1 | active | 2025-07 | internal | |||
smart.who.int.dak-immz | R4 | FXREQCategories | Functional Requirement Categories | active | 2025-04 | internal | |||
smart.who.int.dak-bds | R4 | FXREQCategories | Functional Requirement Categories | active | 2025-07 | internal | |||
smart.who.int.dak-immz | R4 | FXREQBusinessProcesses | Functional Requirements Business Processes | active | 2025-04 | internal | |||
smart.who.int.base | R4 | DecisionTableActions | Smart Guidelines Decision Table Actions | active | 2025-07 | internal | |||
smart.who.int.base | R4 | DocumentationSection | Smart Guidelines Documentation Section | active | 2025-07 | internal | |||
smart.who.int.icvp | R4 | DiseaseTargeted | Disease Targeted | draft | 2025-07 | ||||
smart.who.int.icvp | R4 | ICVPDiseaseTargeted | ICVP Disease Targeted | draft | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.Config.DE12 | HIV burden of the setting ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE17 | Current PrEP regimen ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE122 | PrEP regimen prescribed ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.PRV.DE2 | HIV prevention intervention ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE514 | HIV status of family member ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.H.DE34 | HIV status of partner or contact ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE225 | Infant HIV status ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE115 | HIV status ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE230 | Final diagnosis of HIV-exposed infant ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE789 | STI tested for ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE83 | Current ART regimen (first-, second-, or third-line) ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE449 | Pregnant and breastfeeding status at ART start ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE225 | Treatment failure ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE64 | ARV drug regimen received prior to enrolment ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.C.DE95 | Alternative PEP backbone regimen ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE101 | Alternative third PEP drug ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE461 | Medications dispensed ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE712 | Cervical cancer stage at diagnosis ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE5 | Referred through partner services ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.A.DE30 | Marital Status ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.G.DE29 | Hepatitis B diagnosis ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.G.DE51 | Hepatitis C diagnosis ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE41 | Pregnancy intention in serodiscordant partnerships ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE37 | Partner is from a key population ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE1 | Reason for PrEP visit ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE74 | Type of contact elicited ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE8 | Type of contact or partner for partner services ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE706 | Cervical cancer screening outcome ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.G.DE74 | Syphilis diagnosis ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE1019 | TB status at ART start ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE446 | Coinfection status at ART start ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE247 | Preventing and treating coinfections ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.A.DE13 | Country of birth ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.D.DE903 | Medication/drug ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE593 | Medication status ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.H.DE23 | Outcome from outreach attempt ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE560 | Allergies ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE65 | Existing chronic health conditions ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE146 | ART regimen drug class ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE128 | ART regimen composition ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE183 | EID test number ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE180 | EID sample number ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE186 | EID test number 1 test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE190 | EID test number 2 test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE55 | Facility where client first enrolled in HIV care ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.D.DE939 | TB diagnosis result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE897 | WHO functional status ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.A.DE18 | Gender ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE91 | Gender of infant ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE229 | General care activities recommended ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE6 | Source of gestational age ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE664 | HPV-DNA cervical cancer screening test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE63 | Location ARV drugs received prior to enrolment ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.D.DE162 | HBsAg test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.G.DE18 | HBsAg test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE168 | HBV treatment regimen prescribed ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.D.DE179 | HCV viral load test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.G.DE48 | HCV viral load test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE170 | HCV test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.G.DE43 | HCV test result ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE177 | HCV treatment regimen prescribed ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.D.DE947 | TB treatment history ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.A.DE5 | Referred by ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.A.DE46 | Communication preference(s) ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE444 | ART regimen prescribed ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.D.DE1002 | TB treatment outcome ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE1034 | TB preventive treatment (TPT) status ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE127 | Infant feeding practice ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE731 | Invasive cervical cancer treatment method ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE90 | ART regimen ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE537 | Current medications ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE112 | Contraindications to PrEP usage ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE63 | Screenings and diagnostics for PrEP users ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE173 | Maternal and child health service visit ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE75 | Medications prescribed ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE569 | Family planning method used ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE942 | Method of TB diagnosis ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.H.DE13 | Contact method ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE52 | Delivery mode ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE246 | Blood group and Rh factor ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE399 | Monitoring examinations ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE52 | Facility transferred from ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.H.DE50 | Transfer to facility ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE120 | Site where positive HIV test confirmed ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.D.DE457 | Medications prescribed ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE485 | New regimen after switch to second-line regimen ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.D.DE491 | New regimen after switch to third-line regimen ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.D.DE489 | New regimen(s) after substitution within second-line regimen ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.D.DE495 | New regimen(s) after substitution within third-line regimen ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.D.DE483 | New antiretroviral regimen after substitution within first-line regimen ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.D.DE289 | WHO HIV clinical stage condition or symptom ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE934 | WHO HIV clinical stage condition or symptom ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE172 | Other support services ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE164 | Other support services ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE519 | Other support services ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE152 | Prevention services offered and referrals ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE149 | Prevention services offered and referrals ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE131 | Prevention services offered and referrals ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE158 | Sexual and reproductive health integrated services ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE149 | Sexual and reproductive health integrated services ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE156 | Sexual and reproductive health integrated services ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE74 | Original first-line ART regimen ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.B.DE165 | Offer other clinical services ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE157 | Offer other clinical services ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE753 | Offer other clinical services ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.Config.DE19 | Other priority populations ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.E.DE47 | Pregnancy outcome ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE80 | PrEP product prescribed ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE91 | Preferred PEP backbone regimen ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE99 | Preferred third PEP drug ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE121 | Probable route of transmission ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE217 | Reason ART stopped ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE1 | Reason for visit ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE636 | Reason immunization was not provided ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE370 | Reasons for delayed ART initiation ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.G.DE22 | Reason Hepatitis B test not conducted ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.G.DE35 | Reason Hepatitis C test not done ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE418 | Reason for ARV drug regimen substitution ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE430 | Reason for regimen switch ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.G.DE62 | Reason syphilis test not done ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.H.DE74 | Reason ART stopped ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.H.DE53 | Reason(s) for adherence problem ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE197 | Reason(s) for adherence problem ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE486 | Reason for switch to second-line regimen ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.D.DE492 | Reason for switch to third-line regimen ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.D.DE532 | Reason blood pressure reading not done ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.I.DE2 | Reason for referral ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE646 | Reason malaria prophylaxis not provided ValueSet | active | 2025-07 | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE488 | Reason(s) for substitution within second-line regimen ValueSet | active | 2025-07 | ||||
smart.who.int.hiv | R4 | HIV.D.DE494 | Reason(s) for substitution within third-line regimen ValueSet | active | 2025-07 |